Clinical Trials
Active Biotech, Ipsen reach EUR10m milestone in Phase III...
Active Biotech and Ipsen have announced the recruitment of 600 patients in randomized, placebo-controlled Phase III study of tasquinimod in metastatic castrate-resistant prostate cancer...
Clinical Trials
Peregrine reports results from phase II front-line lung cancer...
Peregrine Pharmaceuticals has announced results from its randomized phase II trial, which is designed to determine overall response rate of carboplatin and paclitaxel with...
Clinical Trials
Circassia reports positive results from Phase II ragweed allergy...
 Circassia, a specialty biopharmaceutical company, has announced positive results from Phase II clinical trial of ragweed allergy therapy.  According to...
Clinical Trials
PhaseBio begins Phase I hypertension study with Vasomera
PhaseBio Pharmaceuticals, a biotechnology company, has initiated Phase I clinical study with its novel compound, Vasomera (PB1046), in patients with Stage 1 and 2...
Clinical Trials
TxCell reports positive immuno-monitoring results from Phase I/II Crohn’s...
TxCell SA, a biotechnology company, has announced positive immuno-monitoring results of the Phase I/II study in Crohn's disease with Ovasave. ...
Clinical Trials
Galena initiates Phase III PRESENT trial for NeuVax
Galena Biopharma has initiated Phase III trial for NeuVax (E75 peptide plus GM-CSF) vaccine in HER2 1+ and 2+ breast cancer patients in the...
Clinical Trials
Genta reports Tesetaxel Phase 2b trial data
Genta's Tesetaxel has demonstrated efficacy in the Phase 2b, confirmatory clinical trial, designed to evaluate the drug in patients with advanced gastric cancer. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.